BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38057203)

  • 21. Radiotherapy or Surgery of the Axilla After a Positive Sentinel Node in Breast Cancer: 10-Year Results of the Randomized Controlled EORTC 10981-22023 AMAROS Trial.
    Bartels SAL; Donker M; Poncet C; Sauvé N; Straver ME; van de Velde CJH; Mansel RE; Blanken C; Orzalesi L; Klinkenbijl JHG; van der Mijle HCJ; Nieuwenhuijzen GAP; Veltkamp SC; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JWS; Belkacemi Y; Petignat P; Schinagl DAX; Coens C; van Tienhoven G; van Duijnhoven F; Rutgers EJT
    J Clin Oncol; 2023 Apr; 41(12):2159-2165. PubMed ID: 36383926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative analysis of axillary nodal burden in ultrasound/biopsy positive axilla vs ultrasound negative sentinel lymph node biopsy positive axilla.
    Tandon M; Ball W; Kirby R; Soumian S; Narayanan S
    Breast Dis; 2019; 38(3-4):93-96. PubMed ID: 30909179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative analysis of the correlation between axillary treatment and upper limb lymphedema].
    Lin Y; Xu Y; Zhang XH; Wang CJ; Sun Q
    Zhonghua Wai Ke Za Zhi; 2019 Sep; 57(9):713-716. PubMed ID: 31474063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axillary lymph node treatment in breast cancer: an update.
    Williams PA; Suggs J; Mangana SH
    J Miss State Med Assoc; 2014 May; 55(5):145-7. PubMed ID: 25112128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional radiotherapy after primary systemic treatment for cN+ breast cancer patients.
    Boersma LJ; Mjaaland I; van Duijnhoven F
    Breast; 2023 Apr; 68():181-188. PubMed ID: 36805769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
    Galimberti V; Cole BF; Zurrida S; Viale G; Luini A; Veronesi P; Baratella P; Chifu C; Sargenti M; Intra M; Gentilini O; Mastropasqua MG; Mazzarol G; Massarut S; Garbay JR; Zgajnar J; Galatius H; Recalcati A; Littlejohn D; Bamert M; Colleoni M; Price KN; Regan MM; Goldhirsch A; Coates AS; Gelber RD; Veronesi U;
    Lancet Oncol; 2013 Apr; 14(4):297-305. PubMed ID: 23491275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk stratification of patients with early breast cancer.
    Roy PG; Chan SM; Ng V; Smith BM; Umeh H; Courtney SP
    Clin Breast Cancer; 2014 Feb; 14(1):68-73. PubMed ID: 24252507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
    Ortega Expósito C; Falo C; Pernas S; Pérez Carton S; Gil Gil M; Ortega R; Pérez Montero H; Stradella A; Martinez E; Laplana M; Salinas S; Luzardo A; Soler T; Fernández Montoli ME; Azcarate J; Guma A; Petit A; Benitez A; Bajen M; Reyes Junca JG; Campos M; Ruiz R; Ponce J; Pla MJ; García Tejedor A
    Breast Cancer Res Treat; 2021 Aug; 189(1):111-120. PubMed ID: 34089119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Risk of Subclinical Breast Cancer-Related Lymphedema by the Extent of Axillary Surgery and Regional Node Irradiation: A Randomized Controlled Trial.
    Boyages J; Vicini FA; Shah C; Koelmeyer LA; Nelms JA; Ridner SH
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):987-997. PubMed ID: 33127493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
    Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
    Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation therapy targets and the risk of breast cancer-related lymphedema: a systematic review and network meta-analysis.
    Shaitelman SF; Chiang YJ; Griffin KD; DeSnyder SM; Smith BD; Schaverien MV; Woodward WA; Cormier JN
    Breast Cancer Res Treat; 2017 Apr; 162(2):201-215. PubMed ID: 28012086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Impact of Regional Nodal Irradiation in Patients With Node-Positive Breast Cancer Treated With Neoadjuvant Systemic Therapy.
    Stecklein SR; Park M; Liu DD; Valle Goffin JJ; Caudle AS; Mittendorf EA; Barcenas CH; Mougalian S; Woodward WA; Valero V; Sahin AA; Yang WT; Shaitelman SF
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):568-577. PubMed ID: 29928946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of Failure in Women Who Have Residual Nodal Disease After Neoadjuvant Chemotherapy for Breast Cancer According to Extent of Lymph Node Surgery.
    Kozak MM; Horst KC; Gutkin PM; Jacobson CE; Walck E; von Eyben R; Dirbas FM
    Clin Breast Cancer; 2020 Oct; 20(5):431-438. PubMed ID: 32522481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiotherapy Use and Incidence of Locoregional Recurrence in Patients With Favorable-Risk, Node-Positive Breast Cancer Enrolled in the SWOG S1007 Trial.
    Jagsi R; Barlow WE; Woodward WA; Connolly E; Mahtani R; Shumway D; Speers C; Stecklein SR; Zeidan Y; Zhang H; Sharma P; Pusztai L; Hortobagyi GN; Kalinsky K
    JAMA Oncol; 2023 Aug; 9(8):1083-1089. PubMed ID: 37410451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.
    Raber BM; Lin H; Shen Y; Shaitelman SF; Bedrosian I
    Ann Surg Oncol; 2019 Dec; 26(13):4346-4354. PubMed ID: 31605340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends on Axillary Surgery in Nondistant Metastatic Breast Cancer Patients Treated Between 2011 and 2015: A Dutch Population-based Study in the ACOSOG-Z0011 and AMAROS Era.
    Poodt IGM; Spronk PER; Vugts G; van Dalen T; Peeters MTFDV; Rots ML; Kuijer A; Nieuwenhuijzen GAP; Schipper RJ
    Ann Surg; 2018 Dec; 268(6):1084-1090. PubMed ID: 28742702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.
    Wang S; Kirova YM; Shan SC; Cai G; Ou D; Cao L; Cai R; Chen JY
    Cancer Radiother; 2018 Dec; 22(8):767-772. PubMed ID: 30523794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome following sentinel lymph node biopsy-guided decisions in breast cancer patients with conversion from positive to negative axillary lymph nodes after neoadjuvant chemotherapy.
    Kang YJ; Han W; Park S; You JY; Yi HW; Park S; Nam S; Kim JH; Yun KW; Kim HJ; Ahn SH; Park S; Lee JE; Lee ES; Noh DY; Lee JW
    Breast Cancer Res Treat; 2017 Nov; 166(2):473-480. PubMed ID: 28766131
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.